I am outraged by the CDC. This is not public health. They are not even talking about the long term damage this disease can do to people and then they pull back on these recommendations . It is outrageous. Similarly they have treated Lyme disease the same way shoveling everything under the rug until it is too late for many.
Thank you for the great info, as always! A quick note that the Trader Joe’s recall is on “chicken soup dumplings” rather than “chicken dumpling soup”. 🥟 vs 🍲. 🙂
Now that we have a vaccine for RSV, what are the prospects for an anti-norovirus vaccine? Or does it not have a big enough impact on the economy to warrant the R&D dollars? Also, do we know how long norovirus can live on surfaces?
There are a few candidates in development but they aren't very far along. After a quick lookup, I think one is beginning a phase 3 trial, the rest are earlier.
With regard to the RSV vaccine, you commented on Guillain-Barré last week.
In Pfizer’s third study noted in its prescribing information, there were 10 cases of atrial fibrillation in the active arm versus 4 cases in the placebo arm. Has data about atrial fibrillation been further evaluated? It would be helpful to be able to present more current data to patients that I have to help evaluate risk versus benefit.
I am outraged by the CDC. This is not public health. They are not even talking about the long term damage this disease can do to people and then they pull back on these recommendations . It is outrageous. Similarly they have treated Lyme disease the same way shoveling everything under the rug until it is too late for many.
Thank you for the great info, as always! A quick note that the Trader Joe’s recall is on “chicken soup dumplings” rather than “chicken dumpling soup”. 🥟 vs 🍲. 🙂
The Midwest always appears as an outlier. Are there different reporting requirements or other attributes that account for that?
Thank you for your information. I so appreciate it.
Now that we have a vaccine for RSV, what are the prospects for an anti-norovirus vaccine? Or does it not have a big enough impact on the economy to warrant the R&D dollars? Also, do we know how long norovirus can live on surfaces?
There are a few candidates in development but they aren't very far along. After a quick lookup, I think one is beginning a phase 3 trial, the rest are earlier.
With regard to the RSV vaccine, you commented on Guillain-Barré last week.
In Pfizer’s third study noted in its prescribing information, there were 10 cases of atrial fibrillation in the active arm versus 4 cases in the placebo arm. Has data about atrial fibrillation been further evaluated? It would be helpful to be able to present more current data to patients that I have to help evaluate risk versus benefit.
I have not seen anything new on this.
At the start of the pandemic, isolation time was 14 days.
No I don't think so, quarantine was 14 days but isolation was shorter.
Ah you're right, it was test-to-exit and quarantine for 14. https://www.washingtonpost.com/health/2020/07/21/how-long-should-you-isolate-if-you-test-positive-coronavirus-new-cdc-guidance-says-10-days-not-14/